Site Search
ARCHIVED: NOT AVAILABLE FOR CREDIT
Multiplex/molecular testing for gastrointestinal infections
The field of molecular diagnostics for gastrointestinal infections has exploded in the past two years. Multiple platforms have been cleared by the FDA for clinical use and more continue to come to market. Evolving issues concerning utilization and implementaion of these new technologies will be discussed in detail.
Originally presented on January 12, 2016, in Salt Lake City, Utah.
Lecture Presenter
 | Marc Roger Couturier, PhD, D(ABMM) Medical Director, Microbial Immunology |
Dr. Couturier is an assistant professor of pathology at the University Of Utah School of Medicine. He received his PhD in medical microbiology and immunology with a specialty in bacteriology from the University of Alberta in Edmonton, Alberta, Canada. Dr. Couturier served as a research associate/post-doctoral fellow at the Alberta Provincial Laboratory for Public Health and completed a medical microbiology fellowship (ABMM) at the University of Utah. His research interests include Helicobacter pylori diagnostics and population prevalence, in particular identifying populations with increased risk of infection and reduced access to medical care. Dr. Couturier also has a research focus aimed at developing improved diagnostics for emerging agents of infectious gastroenteritis. He is board certified in medical microbiology, and a member of the American Society for Microbiology and Infectious Disease Society of America.
Objectives
After this presentation, participants will be able to:
- Understand the traditional approaches to gastroenteritis testing.
- Compare and contrast the available multiplex molecular diagnostic assays for gastroenteritis.
- Discuss test utilization of multiplex molecular diagnostics for gastroenteritis.
Sponsored by:
University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories